Sudarshan Pharma (SUDARSHAN) | Stock Overview & Key Data
Sudarshan Pharma Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: ₹452.70 on September 30, 2024
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Financial Highlights
Profitability
Returns and Earnings
Growth
Peer Performance Comparison
No peer performance data available for this stock.
Ownership & Short Interest
Sudarshan Pharma Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Sudarshan Pharma would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
In the last 52 weeks, Sudarshan Pharma reached a high of ₹452.70 (on October 3, 2024) and a low of ₹24.69 (on May 9, 2025).
Curious about Sudarshan Pharma's size and valuation? Its market capitalization stands at 6.77B. When it comes to valuation, the P/E ratio (trailing twelve months) is 42.62, and the forward P/E (looking ahead) is N/A.
As for dividends, Sudarshan Pharma isn't currently offering a significant yield, or that specific data isn't available right now.
When looking at Sudarshan Pharma, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
No specific competitor data is currently available for comparison in this section.
To get a sense of Sudarshan Pharma's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 13.12%, the Debt to Equity ratio from the most recent quarter is 129.85, and its Gross Profit Margin stands at N/A.
Looking at Sudarshan Pharma's growth, its revenue over the trailing twelve months (TTM) was INR5B. Compared to the same quarter last year (YoY), quarterly revenue grew by 19.60%, and quarterly earnings saw a YoY growth of 51.90%.
Wondering who owns Sudarshan Pharma stock? Company insiders (like executives and directors) hold about 75.35% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.